Table 2.
Intervention group (n = 167) and control group (n = 198) analyses before and after intervention
| Scale and subscale | Intervention group Baseline Median (Q1-Q3) | Intervention group Follow-up Median (Q1-Q3) | Significance p-value2 | Control group Baseline Median (Q1-Q3) | Control group Follow-up Median (Q1-Q3) | Significance p-value2 |
|---|---|---|---|---|---|---|
| P-CAT 3 | ||||||
| Total (13–65) | 45.0 (41.0–48.0) | 45.0 (42.0–48.0) | 0.715 | 44.0 (41.0–48.0) | 44.0 (41.0–48.0) | 0.601 |
| Extent of personalizing care(8–401) | 34. 0 (32.0–38.0) | 34.0 (32.0–37.0) | 0.837 | 33.0 (31.0–36.0) | 34.0 (31.0–36.0) | 0.417 |
| Amount of organizational and environmental support(5–251) | 11.0 (7.0–14.0) | 11.0 (8.0–14.0) | 0. 479 | 11.0 (8.0–15.0) | 11.0 (8.0–15.0) | 0.237 |
| PCQ-S 4 | ||||||
| Total (14–84) | 77.0 (68.0–82.0) | 77.0 (68.0–81.0) | 0.685 | 71.0 (61.0–80.0) | 74.0 (67.0–79.0) | 0.451 |
| Safety(5–301) | 28.0 (25.0–30.0) | 27.0 (25.0–30.0) | 0.942 | 27.0 (25.0–29.0) | 27.0 (24.0–29.0) | 0.693 |
| Everydayness(5–301) | 26.0 (22.0–29.0) | 25.0 (22.0–29.0) | 0.494 | 24.0 (21.0–28.0) | 25.0 (21.0–28.0) | 0.374 |
| Community(4–241) | 23.0 (21.0–24.0) | 23.0 (20.0–24.0) | 0.280 | 22.0 (22.0–24.0) | 22.0 (21.0–24.0) | 0.051 |
1Underlined score is the most favourable score. 2 Wilcoxon Signed Rank Test. Q1 = first quartile; Q3 = third quartile. Significant values are bold. 3Missing n = 10 in intervention group and n = 17 in control group. 4Missing n = 22 in intervention group and n = 33 in control group